A new preparative regimen for stem cell transplant in older patients with severe aplastic anemia
Part of Blood & lymphatic clinical trials.
This study tests a new combination of drugs to prepare older patients (40–60 years old) with severe aplastic anemia for a stem cell transplant from a half-matched donor. The goal is to make the transplant safer and more effective for this age group.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have severe aplastic anemia
- You are between 40 and 60 years old
- You weigh between 100 and 220 pounds (45–100 kg)
- You are able to care for yourself (ECOG score 0–3 means you can manage daily activities with some help if needed)
- Your heart, liver, and kidneys are working reasonably well (no major organ damage)
- You have no active or serious infection
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a lower-dose radiation (TBI) conditioning regimen for stem cell transplants in patients aged 50 and older with aplastic anemia. The goal is to make the transplant safer and more effective for older adults who may not tolerate standard high-dose treatments.
This trial tests a new way to prepare the body for a donor stem cell transplant (allogeneic transplant) in people with severe aplastic anemia or other blood diseases. The goal is to make the transplant safer and more effective.
This trial compares two first treatments for severe aplastic anemia: a half-matched (haploidentical) stem cell transplant versus immune-suppressing medicine. It is for people aged 14–70 who do not have a fully matched sibling donor.
This trial tests a new way of using a mix of donor stem cells (from a half-matched family member and a cord blood unit) to treat aplastic anemia, a condition where the bone marrow stops making enough blood cells. The goal is to see if this transplant approach is safe and helps rebuild healthy blood cells.
This trial tests whether an early bone marrow transplant from a half-matched family member or an unrelated donor can help people with severe aplastic anemia. It aims to restore the body's ability to make healthy blood cells.
This Phase 2 study tests a specific type of donor stem cell transplant for severe bone marrow failure conditions, aiming to improve cure rates while reducing transplant risks. It includes people with diseases like severe aplastic anemia and certain bone marrow disorders, especially when standard transplant plans feel too risky.
Hear when a new Severe Aplastic Anemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.